A detailed history of Wells Fargo & Company transactions in Establishment Labs Holdings Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,257 shares of ESTA stock, worth $233,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,257
Previous 6,151 14.53%
Holding current value
$233,883
Previous $279,000 18.64%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$34.4 - $48.99 $30,753 - $43,797
-894 Reduced 14.53%
5,257 $227,000
Q2 2024

Aug 13, 2024

BUY
$41.46 - $59.86 $217,291 - $313,726
5,241 Added 575.93%
6,151 $279,000
Q1 2024

May 10, 2024

BUY
$24.83 - $51.04 $248 - $510
10 Added 1.11%
910 $46,000
Q4 2023

Feb 09, 2024

SELL
$21.68 - $45.39 $5,615 - $11,756
-259 Reduced 22.35%
900 $23,000
Q3 2023

Nov 13, 2023

BUY
$47.85 - $72.77 $7,895 - $12,007
165 Added 16.6%
1,159 $56,000
Q2 2023

Aug 15, 2023

SELL
$64.29 - $75.89 $1,864 - $2,200
-29 Reduced 2.83%
994 $68,000
Q1 2023

May 12, 2023

BUY
$61.44 - $74.47 $18,309 - $22,192
298 Added 41.1%
1,023 $69,000
Q4 2022

Feb 13, 2023

BUY
$51.0 - $72.94 $4,998 - $7,148
98 Added 15.63%
725 $47,000
Q2 2022

Aug 12, 2022

SELL
$50.15 - $84.52 $298,342 - $502,809
-5,949 Reduced 90.47%
627 $34,000
Q1 2022

May 16, 2022

BUY
$48.73 - $69.9 $59,742 - $85,697
1,226 Added 22.92%
6,576 $443,000
Q4 2021

Feb 14, 2022

SELL
$59.19 - $81.54 $960,002 - $1.32 Million
-16,219 Reduced 75.2%
5,350 $362,000
Q3 2021

Nov 15, 2021

BUY
$65.48 - $88.21 $165,795 - $223,347
2,532 Added 13.3%
21,569 $1.54 Million
Q2 2021

Aug 16, 2021

BUY
$65.47 - $87.34 $1.24 Million - $1.65 Million
18,947 Added 21052.22%
19,037 $1.66 Million
Q1 2021

May 13, 2021

BUY
$36.0 - $73.76 $3,240 - $6,638
90 New
90 $6,000

Others Institutions Holding ESTA

About ESTABLISHMENT LABS HOLDINGS INC.


  • Ticker ESTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,268,500
  • Market Cap $1.08B
  • Description
  • Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone...
More about ESTA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.